Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 569.45
-9.25 (-1.60%)
At close: Feb 12, 2026
Granules India Employees
Granules India had 4,066 employees as of March 31, 2025. The number of employees increased by 9 or 0.22% compared to the previous year.
Employees
4,066
Change (1Y)
9
Growth (1Y)
0.22%
Revenue / Employee
12.52M INR
Profits / Employee
1.34M INR
Market Cap
136.16B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4,066 | 9 | 0.22% |
| Mar 31, 2024 | 4,057 | 407 | 11.15% |
| Mar 31, 2023 | 3,650 | -36 | -0.98% |
| Mar 31, 2022 | 3,686 | 317 | 9.41% |
| Mar 31, 2021 | 3,369 | 340 | 11.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FDC Limited | 6,857 |
| Jubilant Pharmova | 5,547 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| CORONA Remedies | 4,500 |
| Caplin Point Laboratories | 3,966 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| Procter & Gamble Health | 1,326 |
| Viyash Scientific | 1,244 |
Granules India News
- 17 days ago - Granules India shares jump over 4% as Q3 net profit up 28% YoY - Business Upturn
- 20 days ago - Granules India Ltd (BOM:532482) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 20 days ago - Q3 2026 Granules India Ltd Earnings Call Transcript - GuruFocus
- 22 days ago - Pharma sector stocks rally today: Dr. Reddy’s Laboratories up 5%, Granules India jumps 4.33%, Strides Pharma jumps 4% - Business Upturn
- 5 weeks ago - Granules India subsidiary gets FDA tentative approval for generic DYANAVEL XR tablets - Business Upturn
- 7 weeks ago - Granules India board approves fundraise of upto Rs 1,462 crore via issue of warrants at Rs 585 - Business Upturn
- 7 weeks ago - Granules India subsidiary receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets - Business Upturn
- 7 weeks ago - Granules India subsidiary completes USFDA inspection with five procedural observations - Business Upturn